Results of strontium-ythrium-90 for pterygia;Résultat de la thérapie au strontium-yttrium-90 des ptérygions

Journal Francais d'Ophtalmologie

Volumn 25, Issue 5, 2002, Pages 473-479

  Pajic, B ^a   Pugnale Verillotte, N ^b   Greiner, R H ^c   Pajic, D ^b   Eggspuhler A ^d  

^a Klinik Pallas   (Switzerland)

^b Inselspital ^*  (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d Clinique Neurologique Universitaire   (Switzerland)

Author keywords

Pterigium; Strontium ytruim 90; Treatment concept

Indexed keywords

STRONTIUM; STRONTIUM YTTRIUM 90; UNCLASSIFIED DRUG; YTTRIUM 90;

ARTICLE; CONTROLLED STUDY; CORNEA ULCER; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; ELECTRON THERAPY; FRACTIONATION; HUMAN; KERATOPLASTY; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PTERYGIUM; RADIATION DOSE; RECURRENT DISEASE; SCLERA; SURGICAL TECHNIQUE; TELANGIECTASIA; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; PTERYGIUM; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; STRONTIUM RADIOISOTOPES; YTTRIUM RADIOISOTOPES;

EID: 0036274864     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Postoperative irradiation of pterygia: Ten more years of experience
2. Pterygium. A geographical study
3. Pterygium in welders
4. Experiences with surgery and strontium 90 in the treatment of pterygium
5. Postoperative beta radiation treatment of pterygium
6. Recurrence of pterygium after excision
7. Pterygium excision with or without postoperative irradiation, a double blind study
8. Management of pterygium with surgery and radiation therapy
9. Postoperative irradiation for pterygium; Guidelines for optimal treatment
10. Beta-ray application to the eye
11. Treatment of pterygium by surgery followed by beta radiation
12. Histology of pterygium: An electron microscopic study
13. Pterygium as an early indicator of ultraviolet insolation: A hypothesis
14. Pathogenesis of pterygium
15. Risk analysis in the development of pterygia
16. Pterygium and ultraviolet radiation: A positive correlation
17. Aetiology of climatic droplet keratopathy and pterygium
18. Results of prophylactic postoperative irradiation in 1300 cases of pterygium
19. Strontium 90, beta-irradiation, cataractogenicity and pterygium recurrence
20. The use of postoperative beta radiation in the treatment of pterygia
21. Mitomycin eye drops as treatment for pterygium
22. Intraoperative application of topical mitomycin C for pterygium surgery
23. Effectiveness of intraoperative mitomycin C in the treatment of recurrent pterygium
24. Postoperative installation of low-dose mitomycin C in the treatment of primary pterygia
25. Role of mitomycin C in pterygium surgery
26. Lokale mitomycin-c-therapie nach pterygiumexzision
27. Results of treatment with topical mitomycin C 0,02% following excision of primary pterygium
28. The use of mitomycin C in pterygium surgery
29. Pterygium excision using 193-nm excimer laser smoothing and topical mitomycin C
30. Postoperative installation of low-dose mitomycin C in the treatment of primary pterygium
31. A randomised trial comparing Mitomycin C and conjunctival autograft after excision of primary pterygium
32. Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium
33. Late complications of pterygium treatment
34. Recurrent pterygia: Results of postoperative treatment with Sr-90 applicators
35. Cellular changes in the conjunctiva after Strontium 90 treatment for pterygium
36. Long-term complications of beta-radiation therapy in ophthalmology
37. Complications following eye treatment with Sr-90 applicator
38. Management of pterygia 20 years later
39. Preventable complications of pterygium excision with beta-irradiation
40. Irradiation of recurrent pterygia: Results and complications
41. Radiation damage after pterygium treatment
42. Management of pterygium
43. Diseases of the outer eye
44. HLA-DR antigen expression in pterygium epithelial cells and lymphocyte subpopulations: An immunohistochemistry study
45. Immunologic basis for the pathogenesis of pterygium
46. Mast cells and pterygium
47. Antiangiogenesis for cancer therapy
48. Immunological studies on the pathogenesis of pterygium
49. Chemokines-chemotactic cytokines that mediate inflammation
50. Positive and negative regulation of angiogenesis: From cell biology to the clinic
51. Immunohistochemical evidence that pterygia arise from altered limbal epithelial basal stem cells
52. A model for pterygium formation
53. Recurrence rate and complications after beta irradiation for pterygia
54. Severe corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium exzision
55. Pterygium: Clinical classification and management in Virgin Islands
56. Pterygia: Single-fraction postoperative beta irradiation